JP2025500412A5 - - Google Patents
Info
- Publication number
- JP2025500412A5 JP2025500412A5 JP2024537896A JP2024537896A JP2025500412A5 JP 2025500412 A5 JP2025500412 A5 JP 2025500412A5 JP 2024537896 A JP2024537896 A JP 2024537896A JP 2024537896 A JP2024537896 A JP 2024537896A JP 2025500412 A5 JP2025500412 A5 JP 2025500412A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- qol
- patient
- questionnaire
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293070P | 2021-12-22 | 2021-12-22 | |
| US63/293,070 | 2021-12-22 | ||
| US202263305550P | 2022-02-01 | 2022-02-01 | |
| US63/305,550 | 2022-02-01 | ||
| US202263335535P | 2022-04-27 | 2022-04-27 | |
| US63/335,535 | 2022-04-27 | ||
| US202263359717P | 2022-07-08 | 2022-07-08 | |
| US63/359,717 | 2022-07-08 | ||
| US202263382223P | 2022-11-03 | 2022-11-03 | |
| US63/382,223 | 2022-11-03 | ||
| US202263386489P | 2022-12-07 | 2022-12-07 | |
| US63/386,489 | 2022-12-07 | ||
| PCT/US2022/082213 WO2023122713A1 (en) | 2021-12-22 | 2022-12-22 | Fitusiran for use in improving patient-reported outcome in hemophilia patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500412A JP2025500412A (ja) | 2025-01-09 |
| JP2025500412A5 true JP2025500412A5 (cg-RX-API-DMAC7.html) | 2026-01-05 |
Family
ID=85227438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537896A Pending JP2025500412A (ja) | 2021-12-22 | 2022-12-22 | 血友病患者において患者報告アウトカムを改善するのに使用するためのフィツシラン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250064842A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452280A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025500412A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240138572A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022419588A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3243297A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313677A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007894A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202342065A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023122713A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025171279A1 (en) * | 2024-02-09 | 2025-08-14 | Genzyme Corporation | Treatment of hemophilia with fitusiran |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9127274B2 (en) | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| IL308717A (en) | 2015-12-07 | 2024-01-01 | Genzyme Corp | Methods and compositions for treating a serpinc1-associated disorder |
| JP2020530442A (ja) | 2017-07-10 | 2020-10-22 | ジェンザイム・コーポレーション | 血友病を有する対象の出血事象を処置するための方法および組成物 |
| WO2022120291A1 (en) * | 2020-12-06 | 2022-06-09 | Genzyme Corporation | Treatment of hemophilia with fitusiran |
-
2022
- 2022-12-21 TW TW111149131A patent/TW202342065A/zh unknown
- 2022-12-22 MX MX2024007894A patent/MX2024007894A/es unknown
- 2022-12-22 KR KR1020247024462A patent/KR20240138572A/ko active Pending
- 2022-12-22 WO PCT/US2022/082213 patent/WO2023122713A1/en not_active Ceased
- 2022-12-22 IL IL313677A patent/IL313677A/en unknown
- 2022-12-22 CA CA3243297A patent/CA3243297A1/en active Pending
- 2022-12-22 AU AU2022419588A patent/AU2022419588A1/en active Pending
- 2022-12-22 US US18/723,352 patent/US20250064842A1/en active Pending
- 2022-12-22 JP JP2024537896A patent/JP2025500412A/ja active Pending
- 2022-12-22 EP EP22857063.6A patent/EP4452280A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531679A5 (cg-RX-API-DMAC7.html) | ||
| Lai et al. | Recombinant interferon‐α in inoperable hepatocellular carcinoma: a randomized controlled trial | |
| Janson et al. | Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours | |
| Protzer et al. | Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C | |
| ES2555279T3 (es) | Neuroprotección en enfermedades desmielinizantes | |
| ES2235499T3 (es) | Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena. | |
| JP2022123073A (ja) | Efpの治療または低減方法 | |
| CA2542726A1 (en) | Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes | |
| CN1094642A (zh) | 治疗组合物 | |
| WO2011079175A1 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| Shayan et al. | Use of propranolol in treating hemangiomas | |
| TW202417035A (zh) | 提派肽(tirzepatide)組合物及用途 | |
| JP2002510645A5 (cg-RX-API-DMAC7.html) | ||
| WO2022039619A1 (ru) | Противовирусное средство для комбинированной терапии covid-19 (sars-cov-2) | |
| JP2023544249A5 (cg-RX-API-DMAC7.html) | ||
| RU2024120372A (ru) | Фитусиран для применения в улучшении сообщаемого пациентом исхода у пациентов с гемофилией | |
| WO2023028554A1 (en) | Glp-1r agonists for use in a treatment of neurological impairment associated with viral infection | |
| ES2929379T3 (es) | Métodos para el tratamiento de infecciones por coronavirus | |
| Neal | The treatment of acute infections of the central nervous system with sulfanilamide | |
| JP2025500412A (ja) | 血友病患者において患者報告アウトカムを改善するのに使用するためのフィツシラン | |
| BABAMAHMOODI et al. | Combination Therapy with Remdisivir and Tocilizumab for COVID-19: Lessons for Futures Studies (Case Report) | |
| KR20000010880A (ko) | 종양에 대한 숙주 방어 기작의 자극 | |
| RU2389499C1 (ru) | Способ лечения больных с гипербилирубинемией | |
| Loewe et al. | The Prolonging Action of Penicillin by Para-Aminohippuric Acid. | |
| RU2416413C1 (ru) | Средство для лечения кровопотери ("спаскровь") |